Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Lancet (London, England)|September 1, 2009
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran, Alexandra J Lansky, Bernhard Witzenbichler, et al.
Lancet (London, England)|July 30, 2013
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyGregg W Stone, Bernhard Witzenbichler, Giora Weisz, et al.
Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Circulation|April 7, 2005
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialAlexandra J Lansky, Cody Pietras, Ricardo A Costa, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
Pageof 12